Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06563934 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Gut Microbiota in Liver Cancer (Treated With TKIs In Combination With ICIs)

Name: Gut Microbiota in Liver Cancer (Treated With TKIs In Combination With ICIs) — clinical trial record (NCT06563934)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusNot Yet Recruiting

PhasePhase 2

SponsorXu Yong, MD

Started2024-08-30

View on ClinicalTrials.gov ↗

Record status

This record was last updated August 21, 2024 (before its estimated May 20, 2026 completion). Its status may not reflect the trial's current state.

To evaluate the additional efficacy and safety of oral enterobacterial capsules in patients with intermediate and advanced liver cancer and treated with tyrosine kinase inhibitors (TKIs) combined with immunotherapy.

Trial Details

NCT Number	NCT06563934
Lead Sponsor	Xu Yong, MD Collaborators: Nanjing Xiershou Biotechnology Co., Ltd
Conditions	Liver Cancer
Enrollment	70 participants
Start Date	2024-08-30
Primary Completion	2026-05-20 (estimated)
Study Completion	2026-11-20 (estimated)
Updated on ClinicalTrials.gov	2024-08-21